MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
MediGene Max Drawdown (5Y) : 98.50% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 98.50% |
| June 30, 2026 | 98.50% |
| May 31, 2026 | 98.50% |
| April 30, 2026 | 98.50% |
| March 31, 2026 | 98.50% |
| February 28, 2026 | 98.50% |
| January 31, 2026 | 98.50% |
| December 31, 2025 | 98.50% |
| November 30, 2025 | 98.50% |
| October 31, 2025 | 98.50% |
| September 30, 2025 | 98.50% |
| August 31, 2025 | 98.50% |
| July 31, 2025 | 98.50% |
| June 30, 2025 | 98.50% |
| May 31, 2025 | 98.50% |
| April 30, 2025 | 92.24% |
| March 31, 2025 | 92.24% |
| February 28, 2025 | 92.24% |
| January 31, 2025 | 92.24% |
| December 31, 2024 | 92.24% |
| November 30, 2024 | 92.24% |
| October 31, 2024 | 92.24% |
| September 30, 2024 | 92.24% |
| August 31, 2024 | 92.24% |
| July 31, 2024 | 92.24% |
| Date | Value |
|---|---|
| June 30, 2024 | 92.24% |
| May 31, 2024 | 92.24% |
| April 30, 2024 | 92.24% |
| March 31, 2024 | 92.24% |
| February 29, 2024 | 92.24% |
| January 31, 2024 | 92.24% |
| December 31, 2023 | 92.24% |
| November 30, 2023 | 92.24% |
| October 31, 2023 | 92.24% |
| September 30, 2023 | 92.24% |
| August 31, 2023 | 92.24% |
| July 31, 2023 | 92.24% |
| June 30, 2023 | 92.24% |
| May 31, 2023 | 92.24% |
| April 30, 2023 | 92.24% |
| March 31, 2023 | 92.24% |
| February 28, 2023 | 92.24% |
| January 31, 2023 | 92.24% |
| December 31, 2022 | 92.24% |
| November 30, 2022 | 92.24% |
| October 31, 2022 | 92.24% |
| September 30, 2022 | 92.24% |
| August 31, 2022 | 89.54% |
| July 31, 2022 | 89.54% |
| June 30, 2022 | 88.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| InflaRx NV | 98.49% |
| BioNTech SE | 82.24% |
| Immatics NV | 77.36% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -56.50 |
| Beta (5Y) | -0.0891 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.16% |
| Historical Sharpe Ratio (5Y) | -0.9075 |
| Historical Sortino (5Y) | -1.055 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.23% |